Anest. intenziv. Med. 2022;33(6):260-263 | DOI: 10.36290/aim.2022.048

Year 2022 in review - Chronic painReview Article

Fricová J.
Klinika anesteziologie, resuscitace a intenzivní medicíny, Centrum pro léčbu bolesti 1. lékařské fakulty Univerzity Karlovy a Všeobecné fakultní nemocnice, Praha

This article presents a selection of interesting basic research, clinical studies, new recommendations, new definitions of pain, a new type of nociplastic pain, and a completely new type of post-covid headache. Only foreign and relevant sources are discussed.

Keywords: chronic pain, opioid receptors, pain definition, nociplastic pain, potent opioids, medical cannabis, metformin, COVID-19.

Accepted: December 19, 2022; Published: December 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Fricová J. Year 2022 in review - Chronic pain. Anest. intenziv. Med. 2022;33(6):260-263. doi: 10.36290/aim.2022.048.
Download citation

References

  1. Fink EA, Xu J, Hübner H, Braz JM, Seemann P, Avet C, et al. Structure-based discovery of nonopioid analgesics acting through the α2A-adrenergic receptor. Science. 2022;377(6614):eabn7065. doi: 10.1126/science.abn7065. Epub 2022 Sep 30. PMID: 36173843. Go to original source... Go to PubMed...
  2. Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976-1982. doi: 10.1097/j.pain.0000000000001939. PMID: 32694387; PMCID: PMC7680716. Go to original source... Go to PubMed...
  3. Nijs J, Lahousse A, Kapreli E, Bilika P, Saraçoğlu İ, Malfliet A, et al. Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future. J Clin Med. 2021;10(15):3203. doi: 10.3390/jcm10153203. PMID: 34361986; PMCID: PMC8347369. Go to original source... Go to PubMed...
  4. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. PMID: 36327391; PMCID: PMC9639433. Go to original source... Go to PubMed...
  5. Nouhravesh N. Cardiovascular risk following cannabinoid treatment for patients with chronic pain ESC 365 - Cardiovascular risk following cannabinoid treatment for patients with chronic pain (escardio.org).
  6. Tobin DG, Lockwood MB, Kimmel PL, Dember LM, Eneanya ND, Jhamb M, et al; HOPE Consortium. Opioids for chronic pain management in patients with dialysis-dependent kidney failure. Nat Rev Nephrol. 2022;18(2):113-128. doi: 10.1038/s41581-021-00484-6. Epub 2021 Oct 7. PMID: 34621058; PMCID: PMC8792317. Go to original source... Go to PubMed...
  7. Tana C, Bentivegna E, Cho SJ, Harriott AM, García-Azorín D, Labastida-Ramirez A, et al. Long COVID headache. J Headache Pain. 2022;23(1):93. doi: 10.1186/s10194-022-01450-8. PMID: 35915417; PMCID: PMC9340759. Go to original source... Go to PubMed...
  8. Wei J, Wei Y, Huang M, Wang P, Jia S. Is metformin a possible treatment for diabetic neuropathy? J Diabetes. 2022;14(10):658-669. doi: 10.1111/1753-0407.13310. Epub 2022 Sep 18. PMID: 36117320; PMCID: PMC9574743. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.